Home › Funds › AQR Capital Management › FATE
AQR Capital Management position in FATE
FATE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)3.84M sh
Reported value held$10.36M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 36.13K | $2.14M | New |
| Q4 2021 | 26.83K | $1.57M | Reduce |
| Q1 2022 | 15.44K | $599.00K | Reduce |
| Q1 2023 | 271.40K | $1.55M | New |
| Q3 2023 | 332.91K | $705.77K | New |
| Q4 2023 | 235.06K | $879.12K | Reduce |
| Q1 2024 | 22.10K | $162.20K | Reduce |
| Q2 2024 | 16.46K | $53.99K | Reduce |
| Q3 2024 | 24.08K | $84.30K | Add |
| Q4 2024 | 147.60K | $243.54K | Add |
| Q1 2025 | 585.02K | $462.23K | Add |
| Q2 2025 | 846.23K | $947.78K | Add |
| Q3 2025 | 1.13M | $1.43M | Add |
| Q4 2025 | 1.16M | $1.14M | Add |
| Q1 2026 | 3.00M | $3.60M | Add |
| Q2 2026 | 3.84M | $10.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FATE
- BlackRock Inc 7.30M sh · $19.71M · Q2 2026
- Two Sigma Investments 3.59M sh · $9.69M · Q2 2026
- Vanguard Group 8.97M sh · $8.82M · Q4 2025
- Renaissance Technologies 2.98M sh · $8.05M · Q2 2026
- Millennium Management 2.43M sh · $6.57M · Q2 2026
- Goldman Sachs Group 2.05M sh · $5.53M · Q2 2026
- Geode Capital Management 1.32M sh · $3.57M · Q2 2026
- Citadel Advisors 1.09M sh · $2.95M · Q2 2026
- Morgan Stanley 694.58K sh · $1.88M · Q2 2026
- Charles Schwab Investment Management 610.95K sh · $1.65M · Q2 2026
- UBS Group AG 590.18K sh · $1.59M · Q2 2026